Our Founder's work on gut health and Parkinson's was featured in Science News!
by Charlie Genry February 20, 2020
Check out this article about key research on gut health, Parkinson's, and our Founder.
We caught the eye of Science News in late 2019. They shared some of Martha Carlin's journey. How and why our Founder connected the dots between Parkinson's disease and gut health.
It's personal. Finding real world solutions for those suffering from Parkinson's is the mission that drove her to create The Biocollective to do microbiome research and then launch BiotiQuest to sell Prebiotic + probiotic blends based upon The BioCollective's research.
More and more research is showing that our microbiome health is being connected to many conditions and aspects of our overall wellbeing. Here's the Science New's look at one breakthrough that people were talking about:
Behind closed eyes, the brain is carrying out a carefully coordinated night shift. And research into the microbiome raises an intriguing question: how might the activity in our gut influence the sleep that gives this work its opportunity?
When discussing gut health, the conversation usually centers on the microbiome. While balancing gut bacteria remains essential, cutting-edge science highlights another critical component of cellular health: the glycocalyx.
When discussing chronic neurological conditions like Parkinson’s disease, conventional medicine frequently focuses on a single narrative: dopamine depletion. While managing neurotransmitters remains a core part of traditional care, emerging physical chemistry and microbiome research reveal a far broader picture.